ArticleFrontiers in oncology2025
Predicting early recurrence of colorectal cancer liver metastases: an integrative approach using radiomics and machine learning.
Article in Frontiers in oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The overall incidence of liver metastasis in colorectal cancer is as high as 50%, and surgery remains the only potentially curative approach for the metastatic disease. The recurrence rate of liver metastases within one year after surgery is still 60%-70% in clinical practice. Whether we can accurately predict the early recurrence of patients after surgery is one of the most important considerations in formulating the overall treatment strategy. Methods: In this study, we combined radiomics feature extraction with machine learning classification methods to develop a novel strategy for predicting intrahepatic metastases based on imaging radiomics and machine learning. We constructed and systematically evaluated multiple machine learning models to assess their performance. By validating these models on a test set, we determined the effectiveness of each predictive model and selected the one with the highest predictive accuracy. Results: The integration of radiomics and machine learning methods demonstrated significant potential in predicting intrahepatic recurrence within one year after surgery in patients with colorectal cancer liver metastases. The Gradient Boosting, LightGBM, and Random Forest models all achieved classification accuracies (ACC) exceeding 65% across all classification tasks. Notably, the Random Forest model exhibited the best performance; while its classification accuracy was 65.52% in the imaging-only group, it increased to 75.86% when both imaging and clinical information were combined, with an area under the receiver operating characteristic curve (AUC) of 70.83%, indicating strong predictive capability. These findings suggest that these models have potential application value in supporting the diagnostic work of clinical radiologists, potentially helping to reduce workload and decrease the risk of misdiagnosis. Conclusions: The imaging omics model and the combined model have good predictive efficacy for the recurrence of colorectal cancer liver metastases within one year, and can be used to assist in the clinical stratification of postoperative patients and identify high-risk factors for poor prognosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.